Commentary

Rev Diabet Stud, 2005, 2(4):187-189

DOI 10.1900/RDS.2005.2.187

Limitations in Immunotherapy with CD3 Antibodies: Comment on the Article by Drs. Chatenoud and Bach

Damien Bresson, Matthias von Herrath

La Jolla Institute for Allergy and Immunology, Department of Developmental Immunology 3, 10355 Science Center Drive, San Diego, California 92121, USA.
Address correspondence to: Matthias von Herrath, e-mail: matthias@liai.org

Abstract

Fulltext: HTML , PDF (174KB)

Rev Diabet Stud, 2005, 2(4):190-191

DOI 10.1900/RDS.2005.2.190

Response to the Comment by D. Bresson and M. von Herrath

Lucienne Chatenoud, Jean-François Bach

Université René Descartes Paris 5, INSERM U580, Hôpital Necker-Enfants Malades, Paris, France.
Address correspondence to: Jean-François Bach, e-mail: bach@necker.fr

Abstract

Fulltext: HTML , PDF (167KB)